Esomeprazole Market Analysis, Opportunities by 2031
The Esomeprazole Market is expected to register a CAGR of 5.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product (Capsule, Tablet, Others). Futher, it is segmented based on Application (Gastroesophageal Reflux Disease, Duodenal Ulcers, Efficacy, Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Esomeprazole Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Esomeprazole Market Segmentation
Product- Capsule
- Tablet
- Others
- Gastroesophageal Reflux Disease
- Duodenal Ulcers
- Efficacy
- Others
Strategic Insights
Esomeprazole Market Growth Drivers- Incidence of Gastroesophageal Reflux Disease Increasing
- Increasing cases of GERD: The increasing cases of GERD, an ailment where the acidic content keeps returning to the food pipe, have increased the demand for the PPI known as esomeprazole. It is gaining wide popularity since the patients are going to see doctors for heartburn and regurgitation symptoms; hence the increase in market share can be contributed by the drug due to its effectiveness in stopping stomach acid production.
- Increasing Demand for Over-the-Counter (OTC) PPIs: Increased accessibility to esomeprazole due to availability over the counter has led to an increased number of customers. With the increase in self-medication, people buy the medicine without prescription for treating acid reflux and heartburn. Greater accessibility of OTC drugs enhances higher sales volume, and this is what boosts the global market of esomeprazole.
- Research and Development in New Formulations and Treatment Efficiency: Better versions of esomeprazole include extended-release versions, providing more effective therapy and longer periods of symptom relief. Such innovations that result in improved patient outcomes, less frequent dosing, and decreased side effects are what push for the adoption of esomeprazole. Its effectiveness in the treatment of acid-related disorders has been very well spoken of, and this helps to drive its market forward.
- Growing Demand for Proton Pump Inhibitors (PPIs): The increasing incidence of acid-related gastrointestinal disorders, such as GERD, ulcers, and dyspepsia, further increases the demand for PPI esomeprazole. Patients seeking long-term remedy against acid reflux and consequent symptoms will spur an increase in demand for esomeprazole in those geographies with a higher disease incidence rate for digestive health diseases.
- Increasing availability of Over the Counter Esomeprazole: Over-the-counter availability increases the popularity of esomeprazole as a widely used medication for consumers to self-manage heartburn and acid reflux. The demand for convenience, safety, and lower cost with regard to OTC availability will promote the growth of the esomeprazole market and expand its use around the world.
- Focus on Gastrointestinal Health and Wellness:
The increasing health-conscious nature among the consumers and gastrointestinal disorder awareness has led towards demands for effective treatments that come in the form of medicines such as esomeprazole. The market drivers behind esomeprazole rise are the increase of cases like GERD or ulcers, and the concern for their digestive health, which is promoted in preventive care and long term.
- Collaboration with Healthcare Institutes: Clinical trials and research into Esomeprazole can be arranged through strategic collaboration with health care institutions. New applications in the medical arena will be realized and maximum accreditation will be gained. Through such collaborations, Esomeprazole can gain maximum accreditation and credibility, boosting its recognition and adoption in the medical field.
- Formulation Development: Introducing novel formulations of Esomeprazole, including long-acting formulations, can be a potential means of creating competition and also reaching specific patient groups. Modifications to the drug that will make it suitable for treating indications requiring long-term dosing or very accurate release can produce further competitive advantages and broaden the patient population to reach a variety of medical needs, thereby increasing market penetration.
- Heightened Awareness of Gastrointestinal Disorders: Growing awareness about gastrointestinal disorders is creating a lot of openings for Esomeprazole as a treatment. Propagating educational initiatives will increase its usage within clinical settings, thus expanding its market presence. This heightened awareness will contribute to a broader market presence and increased demand for Esomeprazole in clinical settings worldwide.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Esomeprazole Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Esomeprazole Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the esomeprazole market are:
1. Innovation in Drug Delivery Technologies.
2. Increasing GERD.
The esomeprazole market is expected to grow at a CAGR of 5.3%.
North America region accounts for highest revenue share in esomeprazole market.
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%).
Teva and AstraZeneca are the major companies operating in the esomeprazole market.
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023 - 2031).
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Esomeprazole Market - By Product
1.3.2 Esomeprazole Market - By Application
1.3.3 Esomeprazole Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ESOMEPRAZOLE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ESOMEPRAZOLE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ESOMEPRAZOLE MARKET - GLOBAL MARKET ANALYSIS
6.1. ESOMEPRAZOLE - GLOBAL MARKET OVERVIEW
6.2. ESOMEPRAZOLE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ESOMEPRAZOLE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE
7.3.1. Overview
7.3.2. Capsule Market Forecast and Analysis
7.4. TABLET
7.4.1. Overview
7.4.2. Tablet Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ESOMEPRAZOLE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTROESOPHAGEAL REFLUX DISEASE
8.3.1. Overview
8.3.2. Gastroesophageal reflux disease Market Forecast and Analysis
8.4. DUODENAL ULCERS
8.4.1. Overview
8.4.2. Duodenal ulcers Market Forecast and Analysis
8.5. EFFICACY
8.5.1. Overview
8.5.2. Efficacy Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ESOMEPRAZOLE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Esomeprazole Market Overview
9.1.2 North America Esomeprazole Market Forecasts and Analysis
9.1.3 North America Esomeprazole Market Forecasts and Analysis - By Product
9.1.4 North America Esomeprazole Market Forecasts and Analysis - By Application
9.1.5 North America Esomeprazole Market Forecasts and Analysis - By Countries
9.1.5.1 United States Esomeprazole Market
9.1.5.1.1 United States Esomeprazole Market by Product
9.1.5.1.2 United States Esomeprazole Market by Application
9.1.5.2 Canada Esomeprazole Market
9.1.5.2.1 Canada Esomeprazole Market by Product
9.1.5.2.2 Canada Esomeprazole Market by Application
9.1.5.3 Mexico Esomeprazole Market
9.1.5.3.1 Mexico Esomeprazole Market by Product
9.1.5.3.2 Mexico Esomeprazole Market by Application
9.2. EUROPE
9.2.1 Europe Esomeprazole Market Overview
9.2.2 Europe Esomeprazole Market Forecasts and Analysis
9.2.3 Europe Esomeprazole Market Forecasts and Analysis - By Product
9.2.4 Europe Esomeprazole Market Forecasts and Analysis - By Application
9.2.5 Europe Esomeprazole Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Esomeprazole Market
9.2.5.1.1 Germany Esomeprazole Market by Product
9.2.5.1.2 Germany Esomeprazole Market by Application
9.2.5.2 France Esomeprazole Market
9.2.5.2.1 France Esomeprazole Market by Product
9.2.5.2.2 France Esomeprazole Market by Application
9.2.5.3 Italy Esomeprazole Market
9.2.5.3.1 Italy Esomeprazole Market by Product
9.2.5.3.2 Italy Esomeprazole Market by Application
9.2.5.4 Spain Esomeprazole Market
9.2.5.4.1 Spain Esomeprazole Market by Product
9.2.5.4.2 Spain Esomeprazole Market by Application
9.2.5.5 United Kingdom Esomeprazole Market
9.2.5.5.1 United Kingdom Esomeprazole Market by Product
9.2.5.5.2 United Kingdom Esomeprazole Market by Application
9.2.5.6 Rest of Europe Esomeprazole Market
9.2.5.6.1 Rest of Europe Esomeprazole Market by Product
9.2.5.6.2 Rest of Europe Esomeprazole Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Esomeprazole Market Overview
9.3.2 Asia-Pacific Esomeprazole Market Forecasts and Analysis
9.3.3 Asia-Pacific Esomeprazole Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Esomeprazole Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Esomeprazole Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Esomeprazole Market
9.3.5.1.1 Australia Esomeprazole Market by Product
9.3.5.1.2 Australia Esomeprazole Market by Application
9.3.5.2 China Esomeprazole Market
9.3.5.2.1 China Esomeprazole Market by Product
9.3.5.2.2 China Esomeprazole Market by Application
9.3.5.3 India Esomeprazole Market
9.3.5.3.1 India Esomeprazole Market by Product
9.3.5.3.2 India Esomeprazole Market by Application
9.3.5.4 Japan Esomeprazole Market
9.3.5.4.1 Japan Esomeprazole Market by Product
9.3.5.4.2 Japan Esomeprazole Market by Application
9.3.5.5 South Korea Esomeprazole Market
9.3.5.5.1 South Korea Esomeprazole Market by Product
9.3.5.5.2 South Korea Esomeprazole Market by Application
9.3.5.6 Rest of Asia-Pacific Esomeprazole Market
9.3.5.6.1 Rest of Asia-Pacific Esomeprazole Market by Product
9.3.5.6.2 Rest of Asia-Pacific Esomeprazole Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Esomeprazole Market Overview
9.4.2 Middle East and Africa Esomeprazole Market Forecasts and Analysis
9.4.3 Middle East and Africa Esomeprazole Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Esomeprazole Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Esomeprazole Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Esomeprazole Market
9.4.5.1.1 South Africa Esomeprazole Market by Product
9.4.5.1.2 South Africa Esomeprazole Market by Application
9.4.5.2 Saudi Arabia Esomeprazole Market
9.4.5.2.1 Saudi Arabia Esomeprazole Market by Product
9.4.5.2.2 Saudi Arabia Esomeprazole Market by Application
9.4.5.3 U.A.E Esomeprazole Market
9.4.5.3.1 U.A.E Esomeprazole Market by Product
9.4.5.3.2 U.A.E Esomeprazole Market by Application
9.4.5.4 Rest of Middle East and Africa Esomeprazole Market
9.4.5.4.1 Rest of Middle East and Africa Esomeprazole Market by Product
9.4.5.4.2 Rest of Middle East and Africa Esomeprazole Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Esomeprazole Market Overview
9.5.2 South and Central America Esomeprazole Market Forecasts and Analysis
9.5.3 South and Central America Esomeprazole Market Forecasts and Analysis - By Product
9.5.4 South and Central America Esomeprazole Market Forecasts and Analysis - By Application
9.5.5 South and Central America Esomeprazole Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Esomeprazole Market
9.5.5.1.1 Brazil Esomeprazole Market by Product
9.5.5.1.2 Brazil Esomeprazole Market by Application
9.5.5.2 Argentina Esomeprazole Market
9.5.5.2.1 Argentina Esomeprazole Market by Product
9.5.5.2.2 Argentina Esomeprazole Market by Application
9.5.5.3 Rest of South and Central America Esomeprazole Market
9.5.5.3.1 Rest of South and Central America Esomeprazole Market by Product
9.5.5.3.2 Rest of South and Central America Esomeprazole Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ESOMEPRAZOLE MARKET, KEY COMPANY PROFILES
11.1. TEVA, BLASKOV
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRA ZENECA AB
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GARMISH PHARMACEUTICAL
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MEPHA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CQ LUMMY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. STADA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ACTAVIS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MYLAN
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANDOZ
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. SAVAL PHARMACEUTICAL
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
11.12. KERN PHARM
11.12.1. Key Facts
11.12.2. Business Description
11.12.3. Products and Services
11.12.4. Financial Overview
11.12.5. SWOT Analysis
11.12.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Teva, Blaskov
2.Astra Zeneca AB
3.Garmish Pharmaceutical
4.Mepha
5.CQ Lummy
6.Stada
7.Actavis
8.Mylan
9.Sandoz
10.Sanofi
11.Saval Pharmaceutical
12.Kern Pharm
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For